COVID-19 virus affecting clinical trials in Norway
COVID-19 virus affecting clinical trials in Norway
This author has yet to write their bio.Meanwhile lets just say that we are proud Legemiddelindustrien (LMI) and Oslo Cancer Cluster (OCC) contributed a whooping 52 entries.
COVID-19 virus affecting clinical trials in Norway
Talented students learned about immunotherapy at Oslo Cancer Cluster Innovation Park
We wish to expand Oslo Cancer Cluster Innovation Park with close to 50 000 square metres the next five to seven years.
A former Ullern student with an unusual career came to inspire current students in December.
Oslo Cancer Cluster is an oncology research and industry cluster dedicated to improving the lives of cancer patients by accelerating the development of new cancer diagnostics and medicines.
We are a national non-profit member organization with about 90 members. Our members are Norwegian and international companies, research and financial institutions, university hospitals and organizations – all working in the cancer field.